# The Effect of Pharmacist-Initiated Home Blood Pressure Monitoring on Blood Pressure Control in Women

Study · id `cardio:ct-nct05991414` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05991414](<https://clinicaltrials.gov/study/NCT05991414>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05991414

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 368 participants.

## Technical summary

Registry record NCT05991414. Randomized; double masking; primary purpose treatment. Start 2024-01-09 (actual); primary completion 2026-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 368 participants (enrolled count; ClinicalTrials.gov record NCT05991414, source copy `cardio:ctgov-nct05991414-2026-10-23`, retrieved 2026-10-26)
- Started: 2024-01-09 (actual) (ClinicalTrials.gov record NCT05991414, source copy `cardio:ctgov-nct05991414-2026-10-23`, retrieved 2026-10-26)
- Primary completion: 2026-01-31 (actual) (ClinicalTrials.gov record NCT05991414, source copy `cardio:ctgov-nct05991414-2026-10-23`, retrieved 2026-10-26)
- Completion: 2026-08-31 (actual) (ClinicalTrials.gov record NCT05991414, source copy `cardio:ctgov-nct05991414-2026-10-23`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT05991414, source copy `cardio:ctgov-nct05991414-2026-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05991414-2026-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Pharmacist-Initiated Home Blood Pressure Monitoring on Blood Pressure Control in Women
- Condition: Hypertension
- Intervention (Device): Home blood pressure monitor
- Intervention (Procedure): Enhanced community pharmacist care
- Intervention (Procedure): Usual pharmacist care
- Lead sponsor: University of Alberta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of Alberta (`cardio:org-university-of-alberta`)

## Provenance

Content hash: c3851d9a810f51b0e5b7e5c8636fa1011e5111e45aa4eba59a605244ed760d1b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
